DOME
Pre-clinical- Indications
- Brain aneurysm
Company intelligence / Profile preview
LuSeed Vascular’s flagship product, LuSeed DOME™, is a first-in-class minimally invasive device designed to treat both bifurcation and sidewall brain aneurysms. It features a unique dual-layered braided mesh design that allows intuitive delivery from multiple angles with minimal protrusion into parent arteries. This reduces or eliminates the need for chronic dual antiplatelet therapy, improving long-term patient safety. The device enables faster implantation times compared to conventional treatments and is suitable even for ruptured aneurysm cases. It aims to simplify procedures so that physicians with varying experience levels can perform them effectively.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LuSeed Vascular.